Literature DB >> 34136974

Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.

Nghiem B Ha1, Soo-Jin Cho2, Yara Mohamad3, Dorothea Kent1, Grace Jun3, Randi Wong1, Vivek Swarnakar3, Shezhang Lin3, Jacquelyn J Maher1,4, Jennifer C Lai5,6.   

Abstract

BACKGROUND AND AIMS: Accumulation of visceral adipose tissue is associated with hepatic inflammation and fibrosis, suggestive of its metabolic and inflammatory properties. We aimed to examine the histologic findings of visceral and subcutaneous adipose tissue and to associate these findings with clinical and radiologic characteristics in patients with cirrhosis.
METHODS: Included were 55 adults with cirrhosis who underwent liver transplantation from 3/2017-12/2018 and had an abdominal computed tomography (CT) scan within 6 months prior to transplant. Visceral-to-subcutaneous adipose tissue ratio (VSR) was calculated using visceral (VATI) and subcutaneous adipose tissue index (SATI) quantified by CT at the L3-vertebral level and normalized for height (cm2/m2). VAT (greater omentum), SAT (abdominal wall), and skeletal muscle (rectus abdominis) biopsies were collected at transplant.
RESULTS: Majority of patients had VAT inflammation (71%); only one patient (2%) had SAT inflammation. Patients with VAT inflammation had similar median VATI (42 vs 41 cm2/m2), lower median SATI (64 vs 97 cm2/m2), and higher median VSR (0.63 vs 0.37, p = 0.002) than patients without inflammation. In univariable logistic regression, VSR was associated with VAT inflammation (OR 1.47, 95%CI 1.11-1.96); this association remained significant even after adjusting for age, sex, BMI, HCC, or MELD-Na on bivariable analyses.
CONCLUSION: In patients with cirrhosis undergoing liver transplantation, histologic VAT inflammation was common, but SAT inflammation was not. Increased VSR was independently associated with VAT inflammation. Given the emerging data demonstrating the prognostic value of VSR, our findings support the value of CT-quantified VSR as a prognostic marker for adverse outcomes in the liver transplant setting.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Body composition; Liver transplant; Obesity; Subcutaneous adipose tissue; Visceral adiposity

Mesh:

Year:  2021        PMID: 34136974      PMCID: PMC8815298          DOI: 10.1007/s10620-021-07099-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  43 in total

1.  Adipopenia correlates with higher portal pressure in patients with cirrhosis.

Authors:  Susana G Rodrigues; Ben Brabandt; Guido Stirnimann; Martin H Maurer; Annalisa Berzigotti
Journal:  Liver Int       Date:  2019-07-02       Impact factor: 5.828

2.  Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Hisaya Shirai; Shintaro Yagi; Naoko Kamo; Hideaki Okajima; Shinji Uemoto
Journal:  Transplantation       Date:  2017-03       Impact factor: 4.939

3.  Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.

Authors:  Maryam Ebadi; Puneeta Tandon; Carlos Moctezuma-Velazquez; Sunita Ghosh; Vickie E Baracos; Vera C Mazurak; Aldo J Montano-Loza
Journal:  J Hepatol       Date:  2018-04-28       Impact factor: 25.083

4.  Abdominal adiposity, body composition and survival after liver transplantation.

Authors:  Michael N Terjimanian; Calista M Harbaugh; Adnan Hussain; Kola O Olugbade; Seth A Waits; Stewart C Wang; Christopher J Sonnenday; Michael J Englesbe
Journal:  Clin Transplant       Date:  2016-02-13       Impact factor: 2.863

5.  Visceral Adipose Tissue Index and Hepatocellular Carcinoma Are Independent Predictors of Outcome in Patients with Cirrhosis Having Endoscopic Treatment for Esophageal Varices.

Authors:  Naruhiro Kimura; Atsunori Tsuchiya; Chiyumi Oda; Atsushi Kimura; Kazunori Hosaka; Kentaro Tominaga; Kazunao Hayashi; Junji Yokoyama; Shuji Terai
Journal:  Dig Dis       Date:  2020-05-25       Impact factor: 2.404

6.  Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH.

Authors:  T Ohki; R Tateishi; S Shiina; E Goto; T Sato; H Nakagawa; R Masuzaki; T Goto; K Hamamura; F Kanai; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2009-01-27       Impact factor: 23.059

7.  Abdominal Visceral Adipose Tissue is Associated with Myocardial Infarction in Patients with COPD.

Authors:  Alejandro A Diaz; Tom P Young; Sila Kurugol; Erick Eckbo; Nina Muralidhar; Joshua K Chapman; Gregory L Kinney; James C Ross; Raul San Jose Estepar; Rola Harmouche; Jennifer L Black-Shinn; Matthew Budoff; Russell P Bowler; John Hokanson; George R Washko
Journal:  Chronic Obstr Pulm Dis       Date:  2015

8.  Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.

Authors:  Aldo J Montano-Loza; Vera C Mazurak; Maryam Ebadi; Judith Meza-Junco; Michael B Sawyer; Vickie E Baracos; Norman Kneteman
Journal:  Hepatology       Date:  2018-01-26       Impact factor: 17.425

9.  Association between visceral abdominal obesity and long-segment Barrett's esophagus in a Japanese population.

Authors:  Genki Usui; Tomohiro Shinozaki; Toyohisa Jinno; Kazutoshi Fujibayashi; Teppei Morikawa; Toshiaki Gunji; Nobuyuki Matsuhashi
Journal:  J Gastroenterol       Date:  2019-10-30       Impact factor: 7.527

10.  Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis.

Authors:  Chan Hee Jung; Eun Jung Rhee; Hyemi Kwon; Yoosoo Chang; Seungho Ryu; Won Young Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2020-03
View more
  1 in total

1.  Association of myosteatosis with various body composition abnormalities and longer length of hospitalization in patients with decompensated cirrhosis.

Authors:  Xiaoyu Wang; Mingyu Sun; Yifan Li; Gaoyue Guo; Wanting Yang; Lihong Mao; Zihan Yu; Yangyang Hui; Xiaofei Fan; Binxin Cui; Kui Jiang; Chao Sun
Journal:  Front Nutr       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.